Histone cluster 1 H1D inhibitors belong to a specific category of chemical compounds that play a crucial role in the regulation of gene expression and chromatin structure within eukaryotic cells. These inhibitors are designed to target a specific histone subtype known as histone cluster 1 H1D, which is a member of the linker histone family. Histone H1D is distinct from the core histones (H2A, H2B, H3, and H4) and is primarily associated with the packaging of DNA into chromatin, thereby influencing the accessibility of genetic material for various cellular processes.
Histone cluster 1 H1D inhibitors lies in their ability to modulate the interaction between histone H1D and DNA. By binding to histone H1D, these compounds can either enhance or disrupt its affinity for DNA, thereby altering the chromatin structure. This modulation of chromatin structure can have profound effects on gene expression, as it can either facilitate or impede the access of transcription factors and other regulatory proteins to specific genomic regions. Consequently, histone cluster 1 H1D inhibitors are invaluable tools in molecular biology and epigenetics research, as they allow scientists to explore the mechanisms underlying gene regulation and chromatin remodeling. Understanding the intricate interplay between histone H1D and DNA interactions can provide insights into the fundamental processes that govern cell differentiation, development, and response to environmental cues, contributing to our knowledge of how gene expression is finely tuned in various biological contexts.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases (HDACs), leading to increased acetylation of histones and a more relaxed chromatin structure, which can affect the function of H1D by altering its interaction with DNA. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Another HDAC inhibitor that increases histone acetylation, potentially disrupting H1D-mediated chromatin compaction. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A selective HDAC inhibitor that can modify the acetylation status of histones, including those associated with H1D. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that can lead to hyperacetylation of histones, possibly affecting H1D binding and function. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent HDAC inhibitor that can alter chromatin structure and potentially modulate H1D interactions with chromatin. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Selectively inhibits class I HDACs, potentially affecting H1D function by altering chromatin compaction. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $38.00 $113.00 | 14 | |
Inhibits sirtuin histone deacetylases, which could influence H1D function by changing the acetylation state of chromatin. | ||||||
Anacardic Acid | 16611-84-0 | sc-202463 sc-202463A | 5 mg 25 mg | $102.00 $204.00 | 13 | |
Inhibits histone acetyltransferase (HAT) activities, potentially reducing acetylation levels and affecting H1D-mediated chromatin organization. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
Inhibits HATs, which may decrease histone acetylation and influence H1D function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A compound that can inhibit HATs and potentially affect H1D-mediated chromatin remodeling. | ||||||